Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.4B | 1.4B | 1.2B | 1.3B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 328M | 397.3M | 284.2M | 282.8M |
| Other operating expenses | 30M | 56M | 25.1M | 22M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 984M | 841.5M | 851.6M | 904.3M |
| Tax provision | 186M | 182.7M | 155.1M | 167.5M |
| Net income | 799M | 659M | 696.7M | 736.8M |
| Basic EPS | 3.1 | 2.6 | 2.7 | 2.9 |
| Diluted EPS | 3.1 | 2.6 | 2.7 | 2.9 |
| Basic average shares | 250.3M | 250.5M | 251.2M | 251.2M |
| Diluted average shares | 250.7M | 250.9M | 251.5M | 251.3M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 15M | 17.3M | 18.4M | 18.9M |